| Similar Articles |
|---|
 |
Bio-IT World
May 7, 2002
Davies & Levitt |
Bridge Over Troubled Waterford Project For a project that links some of the best institutions and minds in AIDS research in order to produce an effective vaccine that could save millions of lives, funding should be a nonissue. Unfortunately, that is not the case -- and the bio-IT community has to find a way to remedy this issue.   |
Chemistry World
January 13, 2015
Rebecca Trager |
Ansun settles fraud case for $2m Ansun Biopharma has agreed to pay $2 million to settle a criminal and civil case for submitting false and fraudulent claims against grants and a contract with the US National Institutes of Health. |
Chemistry World
June 11, 2015
Rebecca Trager |
US spends billions annually on unreproducible preclinical research Preclinical research that can't be replicated is funded to the tune of about $28 billion in the US annually. |
Chemistry World
September 3, 2009
Sarah Houlton |
New HIV vaccine hope A team of scientists in the US has discovered two new antibodies that could lead to an HIV vaccine. |
U.S. CPSC
April 28, 2004 |
News From the U.S. Consumer Product Safety Commission Kansas man sentenced to 15 months in prison for conspiring to sell illegal fireworks to consumers. CPSC is tracking down that that sell professional grade explosives to consumers, and homes that serve as havens for the manufacture of dangerous fireworks devices. |
Chemistry World
August 4, 2008
Pete Mitchell |
Vaccine failures shake up HIV research Prospects for an HIV vaccine have receded with the July decision by the US government National Institutes of Health (NIH) to cancel trials of its main vaccine candidate. |
Chemistry World
February 6, 2015
Rebecca Trager |
US funder mulls new emeritus award The US National Institutes of Health is exploring a new grant mechanism for emeritus faculty that would let senior investigators exit their NIH research grant supported role. |
Chemistry World
June 2, 2015
Rebecca Trager |
NIH-funded principal investigators fell sharply in 2010 A former senior leader at the US National Institutes of Health has found what he calls a 'startling' decline in the number of principal investigators funded by the agency from between 2010 and the present day. |
Chemistry World
July 8, 2010
Sarah Houlton |
Antibodies spark HIV vaccine hopes These cross-reactive broadly neutralising antibodies bound to and neutralised more than 90 per cent of the HIV strains they were tested against. |
Popular Mechanics
December 1, 2006
Ben Harder |
Fighting HIV by Building a New Killer In the fight to find a cure for AIDS, researchers have invented a viral double agent on a mission to seek out where HIV hides. |
Wired
January 2003
Richard Martin |
Testing the First AIDS Vaccine Medical establishment, government, and Genentech be damned -- Don Francis has never stopped believing. Now he's about to finish testing the first human AIDS vaccine. |
| AskMen.com |
Vaccine Helps Prevent HIV For the first time, an experimental vaccine has prevented infection with the AIDS virus, a watershed event in the deadly epidemic and a surprising result. |
Chemistry World
October 23, 2014
Rebecca Trager |
US agency fast-tracks Ebola vaccine development The US Department of Health and Human Services is fast-tracking tests on an Ebola vaccine by providing $5.8 million under a one-year contract with the Maryland-based biotech company Profectus BioSciences |
Chemistry World
October 15, 2014
Rebecca Trager |
Quotas proposed to back younger US researchers A US politician's plans to introduce quotas to ensure that the National Institutes of Health's grants go to younger researchers is receiving opposition from somewhat surprising quarters -- science advocacy groups. |
Chemistry World
January 13, 2015
Rebecca Trager |
US science funder updates policy on same sex partners Social change has led the US National Institutes of Health to update its policies. |
Information Today
June 16, 2015 |
NIH Plans for the Future of the National Library of Medicine The National Institutes of Health's director, Francis S. Collins, approved the proposed strategic plan for the National Library of Medicine. |
The Motley Fool
September 25, 2007
Brian Orelli |
Cold HIV Vaccine Gets Frozen Phase 2 clinical trials of Merck's HIV vaccine were frozen, leaving the door open for other drugmakers that have vaccines of their own in early trials. Investors, take note. |
Chemistry World
December 3, 2014
Maria Burke |
Ebola vaccine passes first safety hurdle The vaccine was developed collaboratively by scientists at the NIH's National Institute of Allergy and Infectious Diseases, and at Okairos, a biotechnology company acquired by GlaxoSmithKline. |
Fast Company
August 8, 2011
Kate Rockwood |
AIDS Vaccine Conference Despite billions in annual research dollars, the quest for an AIDS vaccine remains elusive. |
Geotimes
November 2004 |
Open Access: Open Debate? Imagine any U.S. citizen having free and open access to research funded with tax dollars. That possibility could be closer to reality than ever before, but Congress must first address some important concerns |
Chemistry World
August 28, 2014
Anthony King |
Cost of scientific misconduct smaller than feared A study has tallied up the costs to a major US research funder of misconduct that lead to retractions, and the price scientists involved paid for their dishonesty. |
Bio-IT World
September 16, 2004
Kevin Davies |
Computing the Genome Boston University's Charles DeLisi explains his involvement with the human genome project and why he has recently turned his attention to systems biology and an AIDS vaccine. |
Reason
June 2005
Kerry Howley |
Scientists for Sale Innovation vs. ethics: Scientists at the NIH have discovered many things over the years, but evidently they haven't yet found a way to balance innovation and objectivity. |
Salon.com
June 9, 2000
Arthur Allen |
Heart of darkness A team of Los Alamos researchers traces AIDS back to the 1930s, blowing a hole in the most recent theory about its origin. |
HHMI Bulletin
May 2011
Amy Maxmen |
Shirley Tilghman: The Future of Science Ultimately, we want to create a biomedical enterprise that produces the best science and brings out the best in the people engaged in it. Today the training path has become too long. |
Chemistry World
October 3, 2014
Rebecca Trager |
US research agencies in limbo Congress adjourned in September to campaign for the mid-term elections without passing a budget for any federal agency, and won't return to work until 12 November. |
Information Today
September 13, 2004
Barbara Quint |
NIH Requires Open Access for Its Funded Medical Research With the NIH's decision, the fast-paced open access movement has picked up even more momentum. |
Registered Rep.
August 1, 2006
John Churchill |
Hall of Shame Robert Brennan: Found guilty of stock fraud and fined $75 million... Meyer Blinder: Sentenced to 46 months in prison for racketeering, money laundering and stock fraud in 1992... etc. |
HBS Working Knowledge
January 5, 2011 |
Funding Unpredictability Around Stem-Cell Research Inflicts Heavy Cost on Scientific Progress Society pays a high price for randomization of research support -- a fact that, sadly, is not recognized by the public, the media, or politicians. |
Chemistry World
August 20, 2014
Maria Burke |
Doctors turn to experimental Ebola treatments The emergency use of an experimental medicine is highly unusual, but the WHO has declared the Ebola outbreak a public health emergency of international concern. |
